Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
29.45
-0.15 (-0.51%)
At close: Dec 5, 2025, 4:00 PM EST
29.15
-0.30 (-1.02%)
After-hours: Dec 5, 2025, 5:58 PM EST
Celldex Therapeutics Market Cap
Celldex Therapeutics has a market cap or net worth of $1.96 billion as of December 5, 2025. Its market cap has increased by 18.08% in one year.
Market Cap
1.96B
Enterprise Value
1.38B
1-Year Change
18.08%
Ranking
Category
Stock Price
$29.45
Market Cap Chart
Since July 23, 2003, Celldex Therapeutics's market cap has increased from $148.10M to $1.96B, an increase of 1,221.36%. That is a compound annual growth rate of 12.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.96B | 16.73% |
| Dec 31, 2024 | 1.68B | -10.56% |
| Dec 29, 2023 | 1.87B | -10.70% |
| Dec 30, 2022 | 2.10B | 16.42% |
| Dec 31, 2021 | 1.80B | 160.11% |
| Dec 31, 2020 | 693.20M | 1,825.56% |
| Dec 31, 2019 | 36.00M | 5.57% |
| Dec 31, 2018 | 34.10M | -91.17% |
| Dec 29, 2017 | 386.20M | 7.76% |
| Dec 30, 2016 | 358.40M | -76.83% |
| Dec 31, 2015 | 1.55B | -5.39% |
| Dec 31, 2014 | 1.64B | -16.73% |
| Dec 31, 2013 | 1.96B | 372.13% |
| Dec 31, 2012 | 415.90M | 262.28% |
| Dec 30, 2011 | 114.80M | -13.10% |
| Dec 31, 2010 | 132.10M | -10.50% |
| Dec 31, 2009 | 147.60M | 17.99% |
| Dec 31, 2008 | 125.10M | 237.20% |
| Dec 31, 2007 | 37.10M | -62.68% |
| Dec 29, 2006 | 99.40M | -28.69% |
| Dec 30, 2005 | 139.40M | -6.44% |
| Dec 31, 2004 | 149.00M | -15.96% |
| Dec 31, 2003 | 177.30M | 19.72% |
View and export this data all the way back to 2003.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |